β-CA-specific inhibitor dithiocarbamate Fc14–584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis

Ashok Aspatwar; Milka Hammaren; Sanni Koskinen; Bruno Luukinen; Harlan Barker; Fabrizio Carta; Claudiu T. Supuran; Mataleena Parikka; Seppo Parkkila

doi:10.1080/14756366.2017.1332056

β-CA-specific inhibitor dithiocarbamate Fc14–584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis

Ashok Aspatwar
, Milka Hammaren
, Sanni Koskinen
, Bruno Luukinen
, Harlan Barker
, Fabrizio Carta
, Claudiu T. Supuran
, Mataleena Parikka
, Seppo Parkkila

Department of Clinical Chemistry

Research output: Contribution to journal › Article › Scientific › peer-review

61 Citations (Scopus)

Original language	English
Pages (from-to)	832-840
Journal	Journal of Enzyme Inhibition and Medicinal Chemistry
Volume	32
Issue number	1
DOIs	https://doi.org/10.1080/14756366.2017.1332056
Publication status	Published - 2017
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Dithiocarbamates
Mycobacterium marinum
beta-carbonic anhydrase
in vivo inhibition
zebrafish embryos

Publication forum classification

Publication forum level 1

Access to Document

10.1080/14756366.2017.1332056Licence: CC BY

http://urn.fi/urn:nbn:fi:uta-201708112261Licence: CC BY

Zebrafish Facility
Parikka, M. (Manager) & Mäkinen, L. (Manager)
Facility/equipment: Research infrastructure

Cite this

Aspatwar, A., Hammaren, M., Koskinen, S., Luukinen, B., Barker, H., Carta, F., Supuran, C. T., Parikka, M., & Parkkila, S. (2017). β-CA-specific inhibitor dithiocarbamate Fc14–584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis. Journal of Enzyme Inhibition and Medicinal Chemistry, 32(1), 832-840. https://doi.org/10.1080/14756366.2017.1332056

@article{bb4021e4c4cd4bffa6b4f4537e5ee282,

title = "β-CA-specific inhibitor dithiocarbamate Fc14–584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis",

keywords = "Dithiocarbamates, Mycobacterium marinum, beta-carbonic anhydrase, in vivo inhibition, zebrafish embryos, Dithiocarbamates, Mycobacterium marinum, beta-carbonic anhydrase, in vivo inhibition, zebrafish embryos",

author = "Ashok Aspatwar and Milka Hammaren and Sanni Koskinen and Bruno Luukinen and Harlan Barker and Fabrizio Carta and Supuran, \{Claudiu T.\} and Mataleena Parikka and Seppo Parkkila",

year = "2017",

doi = "10.1080/14756366.2017.1332056",

language = "English",

volume = "32",

pages = "832--840",

journal = "Journal of Enzyme Inhibition and Medicinal Chemistry",

issn = "1475-6366",

publisher = "American School of Classical Studies at Athens",

number = "1",

}

Aspatwar, A , Hammaren, M, Koskinen, S, Luukinen, B, Barker, H, Carta, F, Supuran, CT, Parikka, M & Parkkila, S 2017, 'β-CA-specific inhibitor dithiocarbamate Fc14–584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis', Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 32, no. 1, pp. 832-840. https://doi.org/10.1080/14756366.2017.1332056

β-CA-specific inhibitor dithiocarbamate Fc14–584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis. / Aspatwar, Ashok ; Hammaren, Milka; Koskinen, Sanni et al.
In: Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 32, No. 1, 2017, p. 832-840.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - β-CA-specific inhibitor dithiocarbamate Fc14–584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis

AU - Aspatwar, Ashok

AU - Hammaren, Milka

AU - Koskinen, Sanni

AU - Luukinen, Bruno

AU - Barker, Harlan

AU - Carta, Fabrizio

AU - Supuran, Claudiu T.

AU - Parikka, Mataleena

AU - Parkkila, Seppo

PY - 2017

Y1 - 2017

KW - Dithiocarbamates

KW - Mycobacterium marinum

KW - beta-carbonic anhydrase

KW - in vivo inhibition

KW - zebrafish embryos

KW - Dithiocarbamates

KW - Mycobacterium marinum

KW - beta-carbonic anhydrase

KW - in vivo inhibition

KW - zebrafish embryos

U2 - 10.1080/14756366.2017.1332056

DO - 10.1080/14756366.2017.1332056

M3 - Article

SN - 1475-6366

VL - 32

SP - 832

EP - 840

JO - Journal of Enzyme Inhibition and Medicinal Chemistry

JF - Journal of Enzyme Inhibition and Medicinal Chemistry

IS - 1

ER -

β-CA-specific inhibitor dithiocarbamate Fc14–584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis

UN SDGs

Keywords

Publication forum classification

Access to Document

Equipment

Zebrafish Facility

Cite this